The Role of Glutathione in Age-Related Macular Degeneration (AMD)

被引:4
|
作者
Brodzka, Sylwia [1 ,2 ]
Baszynski, Jedrzej [1 ]
Rektor, Katarzyna [2 ]
Holderna-Bona, Karolina [1 ]
Stanek, Emilia [1 ]
Kurhaluk, Natalia [3 ]
Tkaczenko, Halina [3 ]
Malukiewicz, Grazyna [4 ]
Wozniak, Alina [5 ]
Kaminski, Piotr [1 ,2 ]
机构
[1] Nicolaus Copernicus Univ Torun, Fac Med, Dept Med Biol & Biochem, Div Ecol & Environm Protect,Coll Medicum Bydgoszcz, M Sklodowska Curie St 9, PL-85094 Bydgoszcz, Poland
[2] Univ Zielona Gora, Inst Biol Sci, Fac Biol Sci, Dept Biotechnol, Prof Z Szafran St 1, PL-65516 Zielona Gora, Poland
[3] Pomeranian Univ Slupsk, Inst Biol, Arciszewski St 22 B, PL-76200 Slupsk, Poland
[4] Nicolaus Copernicus Univ Torun, Univ Hosp 1, Fac Med, Dept Eye Dis,Coll Medicum Bydgoszcz, M Sklodowska Curie St 9, PL-85092 Bydgoszcz, Poland
[5] Nicolaus Copernicus Univ Torun, Fac Med, Dept Med Biol & Biochem, Coll Medicum Bydgoszcz, M Karlowicz St 24, PL-85092 Bydgoszcz, Poland
关键词
age-related macular degeneration; AMD; oxidative stress; glutathione (GSH); glutathione peroxidase (GPx); glutathione reductase (GR); glutathione S-transferase (GST); GSTT1; GSTM1; PIGMENT EPITHELIAL-CELLS; S-TRANSFERASE M1; OXIDATIVE STRESS; GENETIC POLYMORPHISMS; ANTIOXIDANT RESPONSE; PATHOGENESIS; RISK; DAMAGE; PLASMA; ASSOCIATION;
D O I
10.3390/ijms25084158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Age-related macular degeneration (AMD) is a chronic disease that usually develops in older people. Pathogenetic changes in this disease include anatomical and functional complexes. Harmful factors damage the retina and macula. These changes may lead to partial or total loss of vision. The disease can occur in two clinical forms: dry (the progression is slow and gentle) and exudative (wet-progression is acute and severe), which usually starts in the dry form; however, the coexistence of both forms is possible. The etiology of AMD is not fully understood, and the precise mechanisms of the development of this illness are still unknown. Extensive genetic studies have shown that AMD is a multi-factorial disease and that genetic determinants, along with external and internal environmental and metabolic-functional factors, are important risk factors. This article reviews the role of glutathione (GSH) enzymes engaged in maintaining the reduced form and polymorphism in glutathione S-transferase theta-1 (GSTT1) and glutathione S-transferase mu-1 (GSTM1) in the development of AMD. We only chose papers that confirmed the influence of the parameters on the development of AMD. Because GSH is the most important antioxidant in the eye, it is important to know the influence of the enzymes and genetic background to ensure an optimal level of glutathione concentration. Numerous studies have been conducted on how the glutathione system works till today. This paper presents the current state of knowledge about the changes in GSH, GST, GR, and GPx in AMD. GST studies clearly show increased activity in ill people, but for GPx, the results relating to activity are not so clear. Depending on the research, the results also suggest higher and lower GPx activity in patients with AMD. The analysis of polymorphisms in GST genes confirmed that mutations lead to weaker antioxidant barriers and may contribute to the development of AMD; unfortunately, a meta-analysis and some research did not confirm that connection. Unspecific results of many of the parameters that make up the glutathione system show many unknowns. It is so important to conduct further research to understand the exact mechanism of defense functions of glutathione against oxidative stress in the human eye.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Pathogenic aspects of age-related macular degeneration (AMD)
    Bellmann, C.
    Sahel, J. -A.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 : S11 - S16
  • [22] Age-Related Macular Degeneration (AMD): A View to the Future
    Miller, Joan W.
    D'Anieri, Lily L.
    Husain, Deeba
    Miller, John B.
    Vavvas, Demetrios G.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05)
  • [23] Peripapillary atrophy in age-related macular degeneration (AMD)
    Keilhauer, CN
    Schrader, WF
    Bindewald, A
    Holz, FG
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U62 - U62
  • [24] Age-related macular degeneration (AMD): pathogenesis and therapy
    Nowak, Jerzy Z.
    [J]. PHARMACOLOGICAL REPORTS, 2006, 58 (03) : 353 - 363
  • [25] Pathogenesis and treatments of age-related macular degeneration (AMD)
    Nowak, JZ
    [J]. PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 283 - 284
  • [26] A severity scale for age-related macular degeneration (AMD)
    Davis, MD
    Gangnon, RE
    Hubbard, LD
    Lee, LY
    King, WN
    Bressler, SB
    Chew, EY
    Klein, BEK
    Klein, R
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U353 - U353
  • [27] Mast cells in human choroid and their role in age-related macular degeneration (AMD)
    Ribatti, Domenico
    Dammacco, Rosanna
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [28] Patchy choroidal filling in age-related macular degeneration (AMD)
    Schocke, LS
    DuPont, J
    Metelitsina, T
    Grunwald, J
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U278 - U278
  • [29] Systemic complement activation in Age-Related Macular Degeneration (AMD)
    Pollok-Kopp, B.
    Boerncke, F.
    Scholl, H. P.
    Issa, P. C.
    Janzer, S.
    Walier, M.
    Fimmers, R.
    Wienker, T.
    Fritsche, L.
    Weber, B. H.
    Holz, F. G.
    Chong, N. V.
    Oppermann, M.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 58 - 58
  • [30] Gait Characteristics of Age-related Macular Degeneration (AMD) patients
    Varadaraj, Varshini
    Mihailovic, Aleksandra
    Ehrenkranz, Rebecca
    Lesche, Stephen
    Ramulu, Pradeep
    Swenor, Bonnielin K.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)